SlideShare uma empresa Scribd logo
1 de 55
Predicting toxicity after surgery: erectile dysfunction Francesco Montorsi Andrea Gallina Vita-Salute San Raffaele University URI - Urological Research Institure Milan, Italy
Mulhall J. J Urol, 181:462-471, 2009 20-90% Fowler FJ Jr, et al. Urology, 42:622, 1993 Kundu SD, et al. J Urol, 172:2227, 2004 Litwin MS, et al. Urology, 54:503, 1999 Rabbani F, et al. J Urol, 164:1929, 2000 Rozet F, et al. J Urol, 174:908, 2005 Stanford JL, et al. JAMA, 283:354, 2000 Walsh PC, et al. Urology, 55:58, 2000
Burnett AL, et al. J Urol, 178:597-601, 2007
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],WHICH IS THE BEST DEFINITION OF POST-OP ERECTILE FUNCTION RECOVERY
Briganti A, et al. J Sex Med, 2011 [Epub ahead of print]  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Briganti A, et al. J Sex Med, 2011 [Epub ahead of print]  Postop intercoruse and overall sexual satisfaction ,[object Object],[object Object]
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY: 1.  PRE-OPERATIVE FACTORS 3.  POST-OPERATIVE FACTORS 2.  INTRA-OPERATIVE FACTORS a. Extent of NVBV preservation b. Surgical experience c. Surgical technique a. Adequate on demand or rehabilitative treatment a. Pre-operative erectile function b. Patient age c. Age difference between patient and partners d. Comorbidity profile
Rabbani et al J Urol ,164:1929-34,2000 >65 vs <60 yrs p=0.0007 PRE-OPERATIVE FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY Age at surgery
ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY p<0.001 Gallina A, et al. 2011 submitted EF recovery according to age at surgery <55  60.0-64.9 55.0-55.9 65.0-69.9 >70
Rabbani et al J Urol ,164:1929-34,2000 PRE-OPERATIVE FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY Partial vs Full p=0.038 Pre-operative erectile function
ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY >26 22-25 18-21 11-17 1-10 p<0.001 Gallina A, et al. 2011 submitted EF recovery according to pre-operatory IIEF-EF
Charlson Comorbity Index p=0.03 ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY Gallina A, et al. 2011 submitted 0 2+ 1
AGE DIFFERENCE BETWEEN PATIENT AND PARTNER IS A PREDICTIVE FACTOR OF POTENCY RATE FOLLOWING RADICAL PROSTATECTOMY Descazeaud et al, J Urol  2006;176:2594-8 Age difference was an independent predictive factor of  overall potency status following RP   (p=0.008) 200 consecutive patients  treated with RP  with a minimum 1-year follow-up ^ Potency was defined as  erection sufficient for sexual intercourse with vaginal penetration
Novara G et al. J Sex Med 2010; 7:839–845 ,[object Object]
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY: 1.  PRE-OPERATIVE FACTORS 3.  POST-OPERATIVE FACTORS 2.  INTRA-OPERATIVE FACTORS a. Extent of NVBV preservation b. Surgical experience c. Surgical technique a. Adequate on demand or rehabilitative treatment a. Pre-operative erectile function b. Patient age c. Age difference between patien and partners d. Comorbidity profile
Changes in IIEF-5 score after nerve sparing radical prostatectomy showing significant decrease in IIEF-5 score depending on extent of nerve sparing PREDICTION OF POSTOPERATIVE SEXUAL FUNCTION AFTER NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY Michl et al. J Urol 2005,176,227-31 INTRA-OP FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
Ayyathurai et al, BJU Int. 2008;101:833-6.   FACTORS AFFECTING ERECTILE FUNCTION AFTER RADICAL RETROPUBIC PROSTATECTOMY: RESULTS FROM 1620 CONSECUTIVE PATIENTS UNI AND MULTIVARIABLE ANALYSES PREDICTING EF RECOVERY AFTER SURGERY The proportion of men with a return of EF (erectile function sufficient for intercourse) was  directly proportional to the number of previous RRPs  performed by the surgeon:  60%  of men reported a returned of potency from the first 265 RRPs, compared to  75%  from the most recent 265 ( p =0.001).
INTRAFASCIAL NERVE SPARING  RADICAL PROSTATECTOMY Eichelberg C et al . Eur Urol. 2007;51:105-10 Montorsi F et al Eur Urol 2005;48:938–45 Masterson TA, et al. BJU Int. 2008; 101 : 1217-22 . Nielsen ME, et al  J Urol. 2008 180:2557-64 MSKCC series: 6-month EF recovery rates  67% vs 45%,  respectively (p=0.01)
RALP VS OPEN RADICAL PROSTATECTOMY: RETROSPECTIVE COMPARISON OF A SINGLE CENTER Log rank p<0.001 RALP (n=289) 533 patients  treated with bilateral intra-fascial nerve sparing radical prostatectomy RRP (n=244) Buffi N et al, Eur Urol Suppl 2010;58, abstract#81
Low risk of ED   (age  ≤  65 years, IIEF-EF  ≥ 26, CCI  ≤ 1) p < 0.001 RALP VS OPEN RADICAL PROSTATECTOMY: RETROSPECTIVE COMPARISON OF A SINGLE CENTER Intermediate risk of ED   (age 66-69 years or IIEF-EF 11-25,CCI ≤1) RALP RRP p < 0.001 High risk of ED   (age ≥70 years or IIEF-EF ≤10 or CCI ≥2)  RALP RRP p = 0.3 RALP RRP
COMPARISON OF OPEN AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECOMY WITH A BILATERAL INTRAFASCIAL NERVE-SPARING APPROACH: RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES. Gallina et al. 2011, submitted KM curves predicting EF recovery according to surgical approach 6 months 12 months 24 months Open IBNS 28% 42% 51% RALP-IBNS 61% 69% 69%
COMPARISON OF OPEN AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECOMY WITH A BILATERAL INTRAFASCIAL NERVE-SPARING APPROACH: RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES. Gallina et al. 2011, submitted Only preop fully potent patients (IIEF-EF ≥ 26) , aged <65 years 6 months 12 months 24 months Open IBNS 38% 57% 68% RALP-IBNS 71% 81% 81%
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY: 1.  PRE-OPERATIVE FACTORS 3.  POST-OPERATIVE FACTORS 2.  INTRA-OPERATIVE FACTORS a. Extent of NVBV preservation b. Surgical experience c. Surgical technique a. Adequate on demand or rehabilitative treatment a. Pre-operative erectile function b. Patient age c. Age difference between patient and partner d. Comorbidity profile
RECOVERY OF SPONTANEOUS ERECTILE FUNCTION AFTER NSRRP WITH AND WITHOUT EARLY INTRACAVERNOUS INJECTIONS OF ALPROSTADIL: RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL. ,[object Object],[object Object],[object Object],[object Object],Montorsi F et al. J Urol.158:1408-10,1997
RECOVERY OF SPONTANEOUS ERECTILE FUNCTION AFTER NSRRP WITH AND WITHOUT EARLY INTRACAVERNOUS INJECTIONS OF ALPROSTADIL: RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL. Complications in patients treated with alprostadil injections: 3 cases  (19%)   Montorsi F et al. J Urol.158:1408-10,1997 Group 2 Group 1 p value Recovery of spontaneous erection sufficient for satisfactory sexual intercourse 8 (67%) 3 (20%) <0.001
MAY DRUGS ALTER THE PATHOPHYSIOLOGY OF  POST PROSTATECTOMY ED?  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Schwartz et al, J Urol 171:771, 2004
[object Object],MAY DRUGS ALTER THE PATHOPHYSIOLOGY OF  POST PROSTATECTOMY ED?  Schwartz et al, J Urol 171:771, 2004 Pre-op Post-op p Content of SM (%) Group 1 Sildenafil 50 mg 51.5 52.7 ns Content of SM (%) Group 2 Sildenafil 100 mg 42.8 56.9 <0.05
Effects of nightly sildenafil treatment on recovery of spontaneous erections: results *Responders: patients with combined IIEF Q3/4 score of  ≥ 8 and positive response to question:  “ Over the past 4 weeks, have your erections been good enough for satisfactory sexual activity? ”   at 8 weeks after discontinuation of drug Nightly sildenafil (50 – 100 mg)  vs  placebo after 36 weeks of treatment in  123 patients with normal preoperative EF, wishing to return to sexual activity Placebo n=25 Sildenafil n=51 † p=0.0156 Responders  %* † Padma-Nathan  et al. Int J Impot Res;20:479-86,2008
REINVENT: IIEF-EF domain score ≥22 after 2 months of open-label on-demand vardenafil treatment n=138  n=142  n=146  Patients previously on: Patients with IIEF-EF score  ≥22  (%)  Montorsi et al. Eur Urol. 2008;54:924-31 Placebo Vardenafil nightly Vardenafil on-demand
KAPLAN-MEIER CURVES PREDICTING EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN THE OVERALL POPULATION  TREATED WITH BNSRP (N=435) CHRONIC PDE5-I (n=95) ON-DEMAND PDE5-I (n=147) p=0.1 NO TREATMENT (n=193) p<0.001 Briganti A et al, AUA, 2009 % 1 yr % 2 yrs Chronic PDE5-I 62.4 78.5 On demand PDE5-I 48.0 66.9 No treatment 28.1 35.8
KAPLAN-MEIER CURVES: EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN PTS AT LOW RISK OF ED  (age ≤ 65 yrs, IIEF-EF ≥ 26, CCI ≤1 ;  N=184) p=0.04 p=0.5 CHRONIC PDE5-I ON-DEMAND PDE5-I NO TREATMENT NO TREATMENT p=0.02 p=0.8 ON-DEMAND PDE5-I CHRONIC PDE5-I KAPLAN-MEIER CURVES : EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN PTS AT HIGH RISK OF ED  (age ≥ 70 yrs or IIEF-EF ≤ 10 or CCI ≥ 2;  N=136) Briganti A et al, AUA, 2009 % 1 yr % 2 yrs Chronic PDE5-I 77.1 87.1 On demand PDE5-I 74.5 89.8 No treatment 67.2 69.5 % 1 yr % 2 yrs CHRONIC PDE5-I 37.4 67.8 ON DEMAND PDE5-I 30.9 63.7 NO TREATMENT 20.2 23.5
KAPLAN-MEIER CURVES PREDICTING EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN PATIENTS AT INTERMEDIATE RISK OF ED  (age 66-69 yrs or IIEF-EF 11-25, CCI≤1   ;  N=115) p=0.04 p=0.02 NO TREATMENT CHRONIC PDE5-I ON-DEMAND PDE5-I Briganti A et al, AUA, 2009 % 1 yr % 2 yrs CHRONIC PDE5-I 33.2 74.5 ON DEMAND PDE5-I 28.1 52.9 NO TREATMENT 33.3 39.4
Mulhall et al. BJU Int 2010; 105:37-41 ,[object Object],[object Object],[object Object],[object Object]
Initial challenge with sildenafil citrate (4 attempts with 100 mg) Sildenafil 100 mg 3 times/week Erection sufficiently hard for penetration Trimix (papaverine 30 mg/mL, phentolamine 1 mg/mL and PGE1 10 μg/mL) 3 times/week Mulhall et al. BJU Int 2010; 105:37-41
Mulhall et al. BJU Int 2010; 105:37-41 Delaying the start of rehabilitation of EF was associated with poorer outcomes for EF
EF RECOVERY ACCORDING TO TIME  FROM RP TO THERAPY INITIATION ≤ 2 months >2 months Log rank p=0.002 ,[object Object],CONCLUSIONS.   if a post-operative treatment is planned this should be  initiated soon after surgery Gallina A et al, Eur Urol Suppl 2010:58, abstract#82 1-yr 2-yr ≤  2 months 81% 81% > 2 months 50% 71%
AT LEAST ONE PDE5 INHIBITOR DOSE PER WEEK SHOULD BE TAKEN IN ORDER TO IMPROVE ERECTILE FUNCTION RECOVERY  AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY  ,[object Object],[object Object],[object Object],[object Object],Gallina A et al. AUA meeting 2011
AT LEAST ONE PDE5 INHIBITOR DOSE PER WEEK SHOULD BE TAKEN IN ORDER TO IMPROVE ERECTILE FUNCTION RECOVERY  AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY  Gallina A et al. AUA meeting 2011 <1 pill per week ≥ 1 pill per week Log rank p<0.001 KM curves predicting EF recovery according to the number pills taken
AT LEAST ONE PDE5 INHIBITOR DOSE PER WEEK SHOULD BE TAKEN IN ORDER TO IMPROVE ERECTILE FUNCTION RECOVERY  AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY  ,[object Object],[object Object],[object Object],Gallina A et al. AUA meeting 2011
[object Object],[object Object],[object Object],[object Object],[object Object],Müller  A et al. J Sex Med 2009; 6:2806–12
Müller  A et al. J Sex Med 2009; 6:2806–12
Stepwise logistic regression analysis predicting failure to recover natural erections sufficient for intercourse Müller  A et al. J Sex Med 2009; 6:2806–12
[object Object],[object Object],[object Object],Salonia A et al Eur Urol 53:564-70,2008
AVAILABLE TOOLS FOR PREDICTING ERECTILE FUNCTION RECOVERY AFTER RADICAL PROSTATECOTMY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Briganti et al. J Sex Med 2010;7:2521–25
Briganti et al. J Sex Med 2010;7:2521–25 Erectile function recovery in the overall population
Briganti et al. J Sex Med 2010;7:2521–25 Erectile function recovery according to the novel risk stratification
Briganti et al. J Sex Med 2010;7:2521–25 Novel risk stratification according to post-operative treatment No therapy Pro-erectile therapy
Briganti et al. J Sex Med 2010;7:2521–25 Multivariable cox regression analyses predicting EF recovery
Briganti et al. J Sex Med 2010;7:2521–25 RISK STRATIFICATION AUC: 69.1% ,[object Object],[object Object],[object Object]
Eastham JA et al J Urol. 179:2207-10, 2008  ,[object Object],[object Object],[object Object],[object Object]
Eastham JA et al J Urol. 179:2207-10, 2008  Probability of attaining and maintaining trifecta in patient after RP
AUC:77.3% Eastham JA et al J Urol. 179:2207-10, 2008
CONCLUSIONS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 

Mais conteúdo relacionado

Mais procurados

ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewOSUCCC - James
 
ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease
ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease
ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease European School of Oncology
 
3727 - CMF Spine Science sell sheet_r12[1]
3727 - CMF Spine Science sell sheet_r12[1]3727 - CMF Spine Science sell sheet_r12[1]
3727 - CMF Spine Science sell sheet_r12[1]Jackie McLeod
 
Elective Nodal Irradiation #radonc
Elective Nodal Irradiation #radoncElective Nodal Irradiation #radonc
Elective Nodal Irradiation #radoncRichard Simcock
 
Gut talk
Gut talkGut talk
Gut talkmadurai
 
Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...
Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...
Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...Saleh Alsadi
 
Endocrine resistance in breast cancer
Endocrine resistance in breast cancerEndocrine resistance in breast cancer
Endocrine resistance in breast cancerseayat1103
 
Endocrine resistance in breast cancer
Endocrine resistance in breast cancerEndocrine resistance in breast cancer
Endocrine resistance in breast cancerseayat1103
 
Never-smoker with lung cancer in Southern California
Never-smoker with lung cancer in Southern CaliforniaNever-smoker with lung cancer in Southern California
Never-smoker with lung cancer in Southern CaliforniaSai-Hong Ignatius Ou
 
Bc endocrine resistance_2014_a
Bc endocrine resistance_2014_aBc endocrine resistance_2014_a
Bc endocrine resistance_2014_aMauricio Lema
 
ABC1 - B. Kaufman - Endocrine resistance mechanisms and solutions
ABC1 - B. Kaufman - Endocrine resistance mechanisms and solutionsABC1 - B. Kaufman - Endocrine resistance mechanisms and solutions
ABC1 - B. Kaufman - Endocrine resistance mechanisms and solutionsEuropean School of Oncology
 
MET Crusader TKI presentation
MET Crusader TKI presentationMET Crusader TKI presentation
MET Crusader TKI presentationJohnHallick
 
DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)PCRI_2012conf
 
Metastatic Spine Lesions
Metastatic Spine LesionsMetastatic Spine Lesions
Metastatic Spine LesionsAde Wijaya
 
ovarian cancer - angiogenesis
ovarian cancer - angiogenesisovarian cancer - angiogenesis
ovarian cancer - angiogenesisMohamed Abdulla
 
NET Theranostics Research Poster
NET Theranostics Research PosterNET Theranostics Research Poster
NET Theranostics Research PosterIan Alexander
 
Journal club presentation on metastatic bone disesase
Journal club presentation on metastatic bone disesaseJournal club presentation on metastatic bone disesase
Journal club presentation on metastatic bone disesaseVenkat Vinay
 
Peripheral Nerve Catheters
Peripheral Nerve CathetersPeripheral Nerve Catheters
Peripheral Nerve CathetersDr.Mahmoud Abbas
 

Mais procurados (20)

ASTRO 07 PROS IGRT
ASTRO 07 PROS IGRTASTRO 07 PROS IGRT
ASTRO 07 PROS IGRT
 
ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma Review
 
ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease
ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease
ABC1 - O. Pagani - State-of-the-art HT treatment in ER+ disease
 
3727 - CMF Spine Science sell sheet_r12[1]
3727 - CMF Spine Science sell sheet_r12[1]3727 - CMF Spine Science sell sheet_r12[1]
3727 - CMF Spine Science sell sheet_r12[1]
 
Elective Nodal Irradiation #radonc
Elective Nodal Irradiation #radoncElective Nodal Irradiation #radonc
Elective Nodal Irradiation #radonc
 
Gut talk
Gut talkGut talk
Gut talk
 
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest ...
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest ...Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest ...
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest ...
 
Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...
Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...
Australian dental j_97_-_ian_damage_following_removal_of_mandibular_3rd_molar...
 
Endocrine resistance in breast cancer
Endocrine resistance in breast cancerEndocrine resistance in breast cancer
Endocrine resistance in breast cancer
 
Endocrine resistance in breast cancer
Endocrine resistance in breast cancerEndocrine resistance in breast cancer
Endocrine resistance in breast cancer
 
Never-smoker with lung cancer in Southern California
Never-smoker with lung cancer in Southern CaliforniaNever-smoker with lung cancer in Southern California
Never-smoker with lung cancer in Southern California
 
Bc endocrine resistance_2014_a
Bc endocrine resistance_2014_aBc endocrine resistance_2014_a
Bc endocrine resistance_2014_a
 
ABC1 - B. Kaufman - Endocrine resistance mechanisms and solutions
ABC1 - B. Kaufman - Endocrine resistance mechanisms and solutionsABC1 - B. Kaufman - Endocrine resistance mechanisms and solutions
ABC1 - B. Kaufman - Endocrine resistance mechanisms and solutions
 
MET Crusader TKI presentation
MET Crusader TKI presentationMET Crusader TKI presentation
MET Crusader TKI presentation
 
DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)
 
Metastatic Spine Lesions
Metastatic Spine LesionsMetastatic Spine Lesions
Metastatic Spine Lesions
 
ovarian cancer - angiogenesis
ovarian cancer - angiogenesisovarian cancer - angiogenesis
ovarian cancer - angiogenesis
 
NET Theranostics Research Poster
NET Theranostics Research PosterNET Theranostics Research Poster
NET Theranostics Research Poster
 
Journal club presentation on metastatic bone disesase
Journal club presentation on metastatic bone disesaseJournal club presentation on metastatic bone disesase
Journal club presentation on metastatic bone disesase
 
Peripheral Nerve Catheters
Peripheral Nerve CathetersPeripheral Nerve Catheters
Peripheral Nerve Catheters
 

Destaque

Reg sapc 2008
Reg sapc 2008Reg sapc 2008
Reg sapc 2008pks4
 
Robotic prostatectomy – The way forward or is the jury still out ?
Robotic prostatectomy – The way forward or is the jury still out ?Robotic prostatectomy – The way forward or is the jury still out ?
Robotic prostatectomy – The way forward or is the jury still out ?DrNikhilVasdev
 
Prostate Pathology
Prostate PathologyProstate Pathology
Prostate PathologyMCG Urology
 
NurseReview.Org Neurology Part 1
NurseReview.Org Neurology Part 1NurseReview.Org Neurology Part 1
NurseReview.Org Neurology Part 1Nurse ReviewDotOrg
 
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...MedicineAndHealthCancer
 
Nursing crib.com nursing care plan renal failure
Nursing crib.com   nursing care plan renal failureNursing crib.com   nursing care plan renal failure
Nursing crib.com nursing care plan renal failureRafael Laguartilla
 
Emergency Nursing of the Trauma Patient
Emergency Nursing of the Trauma PatientEmergency Nursing of the Trauma Patient
Emergency Nursing of the Trauma PatientKane Guthrie
 
Spinal cord injury presentation
Spinal cord injury presentationSpinal cord injury presentation
Spinal cord injury presentationsshssomsen
 
Nursing care plan hypertension
Nursing care plan hypertensionNursing care plan hypertension
Nursing care plan hypertensionjmarco90
 
Nursing care plan ppt final draft
Nursing care plan ppt final draftNursing care plan ppt final draft
Nursing care plan ppt final draftgntc
 

Destaque (16)

Reg sapc 2008
Reg sapc 2008Reg sapc 2008
Reg sapc 2008
 
Icp
IcpIcp
Icp
 
Robotic prostatectomy – The way forward or is the jury still out ?
Robotic prostatectomy – The way forward or is the jury still out ?Robotic prostatectomy – The way forward or is the jury still out ?
Robotic prostatectomy – The way forward or is the jury still out ?
 
Prostate Pathology
Prostate PathologyProstate Pathology
Prostate Pathology
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
 
NurseReview.Org Neurology Part 1
NurseReview.Org Neurology Part 1NurseReview.Org Neurology Part 1
NurseReview.Org Neurology Part 1
 
Head injury
Head injuryHead injury
Head injury
 
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... 	 Prost...
Prostate Cancer: Causes, Diagnosis, and Treatment Options Bruce B ... Prost...
 
Nursing crib.com nursing care plan renal failure
Nursing crib.com   nursing care plan renal failureNursing crib.com   nursing care plan renal failure
Nursing crib.com nursing care plan renal failure
 
Pathology of Prostate
Pathology of ProstatePathology of Prostate
Pathology of Prostate
 
Emergency Nursing of the Trauma Patient
Emergency Nursing of the Trauma PatientEmergency Nursing of the Trauma Patient
Emergency Nursing of the Trauma Patient
 
Spinal cord injury presentation
Spinal cord injury presentationSpinal cord injury presentation
Spinal cord injury presentation
 
Nursing care plan hypertension
Nursing care plan hypertensionNursing care plan hypertension
Nursing care plan hypertension
 
Spinal injury ppt
Spinal injury pptSpinal injury ppt
Spinal injury ppt
 
Nursing care plan ppt final draft
Nursing care plan ppt final draftNursing care plan ppt final draft
Nursing care plan ppt final draft
 
Prostate Cancer 2013
Prostate Cancer 2013Prostate Cancer 2013
Prostate Cancer 2013
 

Semelhante a NY Prostate Cancer Conference - R. Gallina - Session 7: Predicting toxicity after surgery: erectile dysfunction

ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...
ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...
ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...European School of Oncology
 
analgesia epidural controlada por el pacientE
analgesia epidural controlada por el pacientEanalgesia epidural controlada por el pacientE
analgesia epidural controlada por el pacientERuhama Mtz Zayas
 
Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...
Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...
Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...Dr. Sherry N. Fanous MD, PHD, FIPP, DESA
 
10 settles pelvic floor disorders
10 settles pelvic floor disorders10 settles pelvic floor disorders
10 settles pelvic floor disordersangel4567
 
BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...
BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...
BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...European School of Oncology
 
Iuga adly ebm
Iuga adly ebmIuga adly ebm
Iuga adly ebmbudi1
 
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons... Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...breastcancerupdatecongress
 
RADIATION IN UPPER LIMB TUMORS
RADIATION IN UPPER LIMB TUMORSRADIATION IN UPPER LIMB TUMORS
RADIATION IN UPPER LIMB TUMORSKanhu Charan
 
Mechanical Thrombectomy
Mechanical ThrombectomyMechanical Thrombectomy
Mechanical ThrombectomyPAIRS WEB
 
MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...
MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...
MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...European School of Oncology
 
Radiofrequency ablation in thyroid disease
Radiofrequency ablation in thyroid diseaseRadiofrequency ablation in thyroid disease
Radiofrequency ablation in thyroid diseaseManoZacMathews
 
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - SurgeryECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - SurgeryEuropean School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
Rectal Cancer and Radiotherapy: What is the Clinical Implication of a Complet...
Rectal Cancer and Radiotherapy:What is the Clinical Implication of a Complet...Rectal Cancer and Radiotherapy:What is the Clinical Implication of a Complet...
Rectal Cancer and Radiotherapy: What is the Clinical Implication of a Complet...ensteve
 
Laparoscopic_bupivacine_hysterectomy.pptx
Laparoscopic_bupivacine_hysterectomy.pptxLaparoscopic_bupivacine_hysterectomy.pptx
Laparoscopic_bupivacine_hysterectomy.pptxGulamSarwar31
 
Terapia del cancro colorettale: gestione oncologica - Gastrolearning®
Terapia del cancro colorettale: gestione oncologica - Gastrolearning®Terapia del cancro colorettale: gestione oncologica - Gastrolearning®
Terapia del cancro colorettale: gestione oncologica - Gastrolearning®Gastrolearning
 
La cirugia abierta es el tratamiento de eleccion de los aneurismas popliteos
La cirugia abierta es el tratamiento de eleccion de los aneurismas popliteosLa cirugia abierta es el tratamiento de eleccion de los aneurismas popliteos
La cirugia abierta es el tratamiento de eleccion de los aneurismas popliteosPascual Lozano-Vilardell
 
Radical trachlectomy present status
Radical trachlectomy present statusRadical trachlectomy present status
Radical trachlectomy present statusVeena Agrawal
 

Semelhante a NY Prostate Cancer Conference - R. Gallina - Session 7: Predicting toxicity after surgery: erectile dysfunction (20)

DUO-Eduard García-Cruz
DUO-Eduard García-CruzDUO-Eduard García-Cruz
DUO-Eduard García-Cruz
 
ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...
ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...
ECCLU 2011 - V. Ficarra - Prostate cancer: All the truth about local treatmen...
 
analgesia epidural controlada por el pacientE
analgesia epidural controlada por el pacientEanalgesia epidural controlada por el pacientE
analgesia epidural controlada por el pacientE
 
Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...
Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...
Ultrasonography guided pulsed radio frequency in comparison to fluoroscopy-gu...
 
10 settles pelvic floor disorders
10 settles pelvic floor disorders10 settles pelvic floor disorders
10 settles pelvic floor disorders
 
THA PA vs DAA
THA PA vs DAATHA PA vs DAA
THA PA vs DAA
 
BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...
BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...
BALKAN MCO 2011 - A. Cervantes - Multidisciplinary management of liver metast...
 
Iuga adly ebm
Iuga adly ebmIuga adly ebm
Iuga adly ebm
 
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons... Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 
RADIATION IN UPPER LIMB TUMORS
RADIATION IN UPPER LIMB TUMORSRADIATION IN UPPER LIMB TUMORS
RADIATION IN UPPER LIMB TUMORS
 
Mechanical Thrombectomy
Mechanical ThrombectomyMechanical Thrombectomy
Mechanical Thrombectomy
 
MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...
MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...
MCO 2011 - Slide 24 - G.J. Poston - Spotlight session - Targeted therapies in...
 
Radiofrequency ablation in thyroid disease
Radiofrequency ablation in thyroid diseaseRadiofrequency ablation in thyroid disease
Radiofrequency ablation in thyroid disease
 
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - SurgeryECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
Rectal Cancer and Radiotherapy: What is the Clinical Implication of a Complet...
Rectal Cancer and Radiotherapy:What is the Clinical Implication of a Complet...Rectal Cancer and Radiotherapy:What is the Clinical Implication of a Complet...
Rectal Cancer and Radiotherapy: What is the Clinical Implication of a Complet...
 
Laparoscopic_bupivacine_hysterectomy.pptx
Laparoscopic_bupivacine_hysterectomy.pptxLaparoscopic_bupivacine_hysterectomy.pptx
Laparoscopic_bupivacine_hysterectomy.pptx
 
Terapia del cancro colorettale: gestione oncologica - Gastrolearning®
Terapia del cancro colorettale: gestione oncologica - Gastrolearning®Terapia del cancro colorettale: gestione oncologica - Gastrolearning®
Terapia del cancro colorettale: gestione oncologica - Gastrolearning®
 
La cirugia abierta es el tratamiento de eleccion de los aneurismas popliteos
La cirugia abierta es el tratamiento de eleccion de los aneurismas popliteosLa cirugia abierta es el tratamiento de eleccion de los aneurismas popliteos
La cirugia abierta es el tratamiento de eleccion de los aneurismas popliteos
 
Radical trachlectomy present status
Radical trachlectomy present statusRadical trachlectomy present status
Radical trachlectomy present status
 

Mais de European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 
J.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artJ.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artEuropean School of Oncology
 

Mais de European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 
J.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artJ.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the art
 

Último

Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...tanya dube
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...Arohi Goyal
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Kochi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kochi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kochi Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...chandars293
 
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...perfect solution
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...astropune
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeCall Girls Delhi
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Ishani Gupta
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Sheetaleventcompany
 

Último (20)

Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Kochi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kochi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kochi Just Call 8250077686 Top Class Call Girl Service Available
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
 
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 

NY Prostate Cancer Conference - R. Gallina - Session 7: Predicting toxicity after surgery: erectile dysfunction

  • 1. Predicting toxicity after surgery: erectile dysfunction Francesco Montorsi Andrea Gallina Vita-Salute San Raffaele University URI - Urological Research Institure Milan, Italy
  • 2. Mulhall J. J Urol, 181:462-471, 2009 20-90% Fowler FJ Jr, et al. Urology, 42:622, 1993 Kundu SD, et al. J Urol, 172:2227, 2004 Litwin MS, et al. Urology, 54:503, 1999 Rabbani F, et al. J Urol, 164:1929, 2000 Rozet F, et al. J Urol, 174:908, 2005 Stanford JL, et al. JAMA, 283:354, 2000 Walsh PC, et al. Urology, 55:58, 2000
  • 3. Burnett AL, et al. J Urol, 178:597-601, 2007
  • 4.
  • 5.
  • 6.
  • 7. FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY: 1. PRE-OPERATIVE FACTORS 3. POST-OPERATIVE FACTORS 2. INTRA-OPERATIVE FACTORS a. Extent of NVBV preservation b. Surgical experience c. Surgical technique a. Adequate on demand or rehabilitative treatment a. Pre-operative erectile function b. Patient age c. Age difference between patient and partners d. Comorbidity profile
  • 8. Rabbani et al J Urol ,164:1929-34,2000 >65 vs <60 yrs p=0.0007 PRE-OPERATIVE FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY Age at surgery
  • 9. ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY p<0.001 Gallina A, et al. 2011 submitted EF recovery according to age at surgery <55 60.0-64.9 55.0-55.9 65.0-69.9 >70
  • 10. Rabbani et al J Urol ,164:1929-34,2000 PRE-OPERATIVE FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY Partial vs Full p=0.038 Pre-operative erectile function
  • 11. ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY >26 22-25 18-21 11-17 1-10 p<0.001 Gallina A, et al. 2011 submitted EF recovery according to pre-operatory IIEF-EF
  • 12. Charlson Comorbity Index p=0.03 ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY Gallina A, et al. 2011 submitted 0 2+ 1
  • 13. AGE DIFFERENCE BETWEEN PATIENT AND PARTNER IS A PREDICTIVE FACTOR OF POTENCY RATE FOLLOWING RADICAL PROSTATECTOMY Descazeaud et al, J Urol 2006;176:2594-8 Age difference was an independent predictive factor of overall potency status following RP (p=0.008) 200 consecutive patients treated with RP with a minimum 1-year follow-up ^ Potency was defined as erection sufficient for sexual intercourse with vaginal penetration
  • 14.
  • 15. FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY: 1. PRE-OPERATIVE FACTORS 3. POST-OPERATIVE FACTORS 2. INTRA-OPERATIVE FACTORS a. Extent of NVBV preservation b. Surgical experience c. Surgical technique a. Adequate on demand or rehabilitative treatment a. Pre-operative erectile function b. Patient age c. Age difference between patien and partners d. Comorbidity profile
  • 16. Changes in IIEF-5 score after nerve sparing radical prostatectomy showing significant decrease in IIEF-5 score depending on extent of nerve sparing PREDICTION OF POSTOPERATIVE SEXUAL FUNCTION AFTER NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY Michl et al. J Urol 2005,176,227-31 INTRA-OP FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
  • 17. Ayyathurai et al, BJU Int. 2008;101:833-6. FACTORS AFFECTING ERECTILE FUNCTION AFTER RADICAL RETROPUBIC PROSTATECTOMY: RESULTS FROM 1620 CONSECUTIVE PATIENTS UNI AND MULTIVARIABLE ANALYSES PREDICTING EF RECOVERY AFTER SURGERY The proportion of men with a return of EF (erectile function sufficient for intercourse) was directly proportional to the number of previous RRPs performed by the surgeon: 60% of men reported a returned of potency from the first 265 RRPs, compared to 75% from the most recent 265 ( p =0.001).
  • 18. INTRAFASCIAL NERVE SPARING RADICAL PROSTATECTOMY Eichelberg C et al . Eur Urol. 2007;51:105-10 Montorsi F et al Eur Urol 2005;48:938–45 Masterson TA, et al. BJU Int. 2008; 101 : 1217-22 . Nielsen ME, et al J Urol. 2008 180:2557-64 MSKCC series: 6-month EF recovery rates 67% vs 45%, respectively (p=0.01)
  • 19. RALP VS OPEN RADICAL PROSTATECTOMY: RETROSPECTIVE COMPARISON OF A SINGLE CENTER Log rank p<0.001 RALP (n=289) 533 patients treated with bilateral intra-fascial nerve sparing radical prostatectomy RRP (n=244) Buffi N et al, Eur Urol Suppl 2010;58, abstract#81
  • 20. Low risk of ED (age ≤ 65 years, IIEF-EF ≥ 26, CCI ≤ 1) p < 0.001 RALP VS OPEN RADICAL PROSTATECTOMY: RETROSPECTIVE COMPARISON OF A SINGLE CENTER Intermediate risk of ED (age 66-69 years or IIEF-EF 11-25,CCI ≤1) RALP RRP p < 0.001 High risk of ED (age ≥70 years or IIEF-EF ≤10 or CCI ≥2) RALP RRP p = 0.3 RALP RRP
  • 21. COMPARISON OF OPEN AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECOMY WITH A BILATERAL INTRAFASCIAL NERVE-SPARING APPROACH: RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES. Gallina et al. 2011, submitted KM curves predicting EF recovery according to surgical approach 6 months 12 months 24 months Open IBNS 28% 42% 51% RALP-IBNS 61% 69% 69%
  • 22. COMPARISON OF OPEN AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECOMY WITH A BILATERAL INTRAFASCIAL NERVE-SPARING APPROACH: RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES. Gallina et al. 2011, submitted Only preop fully potent patients (IIEF-EF ≥ 26) , aged <65 years 6 months 12 months 24 months Open IBNS 38% 57% 68% RALP-IBNS 71% 81% 81%
  • 23. FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY: 1. PRE-OPERATIVE FACTORS 3. POST-OPERATIVE FACTORS 2. INTRA-OPERATIVE FACTORS a. Extent of NVBV preservation b. Surgical experience c. Surgical technique a. Adequate on demand or rehabilitative treatment a. Pre-operative erectile function b. Patient age c. Age difference between patient and partner d. Comorbidity profile
  • 24.
  • 25. RECOVERY OF SPONTANEOUS ERECTILE FUNCTION AFTER NSRRP WITH AND WITHOUT EARLY INTRACAVERNOUS INJECTIONS OF ALPROSTADIL: RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL. Complications in patients treated with alprostadil injections: 3 cases (19%) Montorsi F et al. J Urol.158:1408-10,1997 Group 2 Group 1 p value Recovery of spontaneous erection sufficient for satisfactory sexual intercourse 8 (67%) 3 (20%) <0.001
  • 26.
  • 27.
  • 28. Effects of nightly sildenafil treatment on recovery of spontaneous erections: results *Responders: patients with combined IIEF Q3/4 score of ≥ 8 and positive response to question: “ Over the past 4 weeks, have your erections been good enough for satisfactory sexual activity? ” at 8 weeks after discontinuation of drug Nightly sildenafil (50 – 100 mg) vs placebo after 36 weeks of treatment in 123 patients with normal preoperative EF, wishing to return to sexual activity Placebo n=25 Sildenafil n=51 † p=0.0156 Responders %* † Padma-Nathan et al. Int J Impot Res;20:479-86,2008
  • 29. REINVENT: IIEF-EF domain score ≥22 after 2 months of open-label on-demand vardenafil treatment n=138 n=142 n=146 Patients previously on: Patients with IIEF-EF score ≥22 (%) Montorsi et al. Eur Urol. 2008;54:924-31 Placebo Vardenafil nightly Vardenafil on-demand
  • 30. KAPLAN-MEIER CURVES PREDICTING EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN THE OVERALL POPULATION TREATED WITH BNSRP (N=435) CHRONIC PDE5-I (n=95) ON-DEMAND PDE5-I (n=147) p=0.1 NO TREATMENT (n=193) p<0.001 Briganti A et al, AUA, 2009 % 1 yr % 2 yrs Chronic PDE5-I 62.4 78.5 On demand PDE5-I 48.0 66.9 No treatment 28.1 35.8
  • 31. KAPLAN-MEIER CURVES: EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN PTS AT LOW RISK OF ED (age ≤ 65 yrs, IIEF-EF ≥ 26, CCI ≤1 ; N=184) p=0.04 p=0.5 CHRONIC PDE5-I ON-DEMAND PDE5-I NO TREATMENT NO TREATMENT p=0.02 p=0.8 ON-DEMAND PDE5-I CHRONIC PDE5-I KAPLAN-MEIER CURVES : EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN PTS AT HIGH RISK OF ED (age ≥ 70 yrs or IIEF-EF ≤ 10 or CCI ≥ 2; N=136) Briganti A et al, AUA, 2009 % 1 yr % 2 yrs Chronic PDE5-I 77.1 87.1 On demand PDE5-I 74.5 89.8 No treatment 67.2 69.5 % 1 yr % 2 yrs CHRONIC PDE5-I 37.4 67.8 ON DEMAND PDE5-I 30.9 63.7 NO TREATMENT 20.2 23.5
  • 32. KAPLAN-MEIER CURVES PREDICTING EF RECOVERY ACCORDING TO THE TYPE OF TREATMENT IN PATIENTS AT INTERMEDIATE RISK OF ED (age 66-69 yrs or IIEF-EF 11-25, CCI≤1 ; N=115) p=0.04 p=0.02 NO TREATMENT CHRONIC PDE5-I ON-DEMAND PDE5-I Briganti A et al, AUA, 2009 % 1 yr % 2 yrs CHRONIC PDE5-I 33.2 74.5 ON DEMAND PDE5-I 28.1 52.9 NO TREATMENT 33.3 39.4
  • 33.
  • 34. Initial challenge with sildenafil citrate (4 attempts with 100 mg) Sildenafil 100 mg 3 times/week Erection sufficiently hard for penetration Trimix (papaverine 30 mg/mL, phentolamine 1 mg/mL and PGE1 10 μg/mL) 3 times/week Mulhall et al. BJU Int 2010; 105:37-41
  • 35. Mulhall et al. BJU Int 2010; 105:37-41 Delaying the start of rehabilitation of EF was associated with poorer outcomes for EF
  • 36.
  • 37.
  • 38. AT LEAST ONE PDE5 INHIBITOR DOSE PER WEEK SHOULD BE TAKEN IN ORDER TO IMPROVE ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY Gallina A et al. AUA meeting 2011 <1 pill per week ≥ 1 pill per week Log rank p<0.001 KM curves predicting EF recovery according to the number pills taken
  • 39.
  • 40.
  • 41. Müller A et al. J Sex Med 2009; 6:2806–12
  • 42. Stepwise logistic regression analysis predicting failure to recover natural erections sufficient for intercourse Müller A et al. J Sex Med 2009; 6:2806–12
  • 43.
  • 44. AVAILABLE TOOLS FOR PREDICTING ERECTILE FUNCTION RECOVERY AFTER RADICAL PROSTATECOTMY
  • 45.
  • 46. Briganti et al. J Sex Med 2010;7:2521–25 Erectile function recovery in the overall population
  • 47. Briganti et al. J Sex Med 2010;7:2521–25 Erectile function recovery according to the novel risk stratification
  • 48. Briganti et al. J Sex Med 2010;7:2521–25 Novel risk stratification according to post-operative treatment No therapy Pro-erectile therapy
  • 49. Briganti et al. J Sex Med 2010;7:2521–25 Multivariable cox regression analyses predicting EF recovery
  • 50.
  • 51.
  • 52. Eastham JA et al J Urol. 179:2207-10, 2008 Probability of attaining and maintaining trifecta in patient after RP
  • 53. AUC:77.3% Eastham JA et al J Urol. 179:2207-10, 2008
  • 54.
  • 55.  

Notas do Editor

  1. Introduction and Objective: A significant number of patients experience erectile dysfunction (ED) following a nerve-sparing retropubic radical prostatectomy (NSRRP). This results from smooth muscle degeneration secondary to neurapraxia and hypoxia. Early postoperative intervention with intracavernosal alprostadil may improve the return of erections post-NSRRP. Independently, it has been observed that sildenafil improves nocturnal erections. This study examines the effect of nightly sildenafil administration on the return of normal erections following bilateral NSRRP. Methods: This study included 76 men with normal preoperative erectile function, defined as a combined score of ³8 for questions (Q) 3 and 4 from the International Index of Erectile Function (IIEF) and normal nocturnal penile tumescence (NPT) testing (³10 continuous minutes of ³55% base rigidity), scheduled to undergo a bilateral NSRRP performed by an experienced surgeon. Four weeks postsurgery, patients were randomized to either sildenafil (50 mg, n=23; 100 mg, n=28) or placebo (n=25) and entered a 36-week, double-blind treatment period with nightly drug administration (qhs). Erectile function was assessed 8 weeks after discontinuation of drug treatment (week 48) by asking the question &amp;quot;Over the past 4 weeks, have your erections been good enough for satisfactory sexual activity?&amp;quot; and by IIEF and NPT assessments. Responders were defined as those having a combined score of ³8 for IIEF Q3/4 and a positive response to the above question. Results: Forty-eight weeks after bilateral NSRRP, 14 of 51 (27%) patients receiving sildenafil demonstrated return of spontaneous erectile function compared with 1 of 25 (4%) in the placebo group ( P =0.0156). Postoperative NPT assessments were supportive. There were no treatment-related serious adverse events (AEs) reported; 2 patients discontinued due to treatment-related AEs. Conclusions: Nightly administration of sildenafil for 9 months post-NSRRP increased the return of spontaneous erections 7-fold compared with placebo and was well tolerated. Sildenafil may improve oxygenation at the time of nocturnal erections and/or neuronal regeneration. These results support the consideration of this treatment regimen as an adjunct to NSRRP.